Synthetic antioxidant TS-13 reduces doxorubicin cardiotoxicity
The antitumor antibiotic doxorubicin, a representative of a large group of anthriacyclines, is widely and quite effectively used to treat patients with malignant neoplasms. The aim of this study was to study the effect of TS-13, a synthetic phenolic antioxidant and an activator of the antioxidant-re...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
Russian Academy of Sciences, Siberian Branch Publishing House
2023-10-01
|
| Edice: | Сибирский научный медицинский журнал |
| Témata: | |
| On-line přístup: | https://sibmed.elpub.ru/jour/article/view/1248 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|